|
The 4-S (Signal acquisition, Signal
interpretation, Signal representation and Signal execution) system is the core
technology that Pharmacom invented for performing genomic and proteomic
profiling at real-time and on a same platform. The microelectronic and
nanotechnology-based biosensing systems are designed to capture electronic,
optical, chemical, and biochemical signals that were generated mainly through
molecular interactions, to analyze captured signals at real time through
"on-line" genomic/proteomic algorithms and "on-board" data mining mechanism, to
execute high-speed data transfer through an infrastructure network, internet or
wireless interface, and to trigger a predefined chemical reaction, biological
procedure, mechanical motion or human response.
We are particularly interested at
the methodologies, technical innovations and viable applications of detection
technologies:
B Cell-Based Sensors for
Rapid Identification
Portable Luminescence Immunoassay Technology
Real Time PCR without Amplification
Fluorescence Detection Technology
Enhancement of PCR and Biosensor Detection
State-of-the-Art PCR-Mass Spectrometry
Solid State Microsensors
Bacteriophage Amplification
Surface Plasmon-Coupled Emission
Matrix-Assisted Laser Desorption/Ionization MALDI-MS for Rapid Screening
Phontonic Biosensing Smart Material
DNA Microarray Technology
Nanoelectrode Array for Rapid DNA/RNA Analysis
Multiwalled Carbon Nanotube Electrodes |